An observational study in Hyponatremia, Covid19 and Corona Virus Infection, sponsored by Hospital Nacional Profesor Alejandro Posadas. Completed at 1 site in Argentina. Open to participants aged 1 Month to 100 Years. Per ClinicalTrials.gov, last updated 2020-07-30.
Sponsored by Hospital Nacional Profesor Alejandro Posadas · Observational
SYSTEMIC INFLAMMATION HAS BEEN ASSOCIATED WITH SEVERE COVID-19. HYPONATREMIA CAN RESULT FROM INFLAMMATION DUE TO NON-OSMOTIC STIMULI FOR VASOPRESSIN PRODUCTION. IN THIS PROSPECTIVE COHORT STUDY WE ANALIZED DATA FROM PATIENTS WITH COVID-19 AND THE ASOCIATION WITH HYPONATREMIA AND CLINICAL OUTCOMES.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 250 is close to the median of 261 across 3,136 observational studies indexed under COVID-19.
Browse COVID-19 studies →Hospital Nacional Profesor Alejandro Posadas is the lead sponsor of 8 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
GENERAL POPULATION
Exclusion Criteria:
-
MORTALITY
HYPONATREMIA AND MORTALITY
Time frame: 30 DAYS
ICU HOSPITALIZATION
HYPONATREMIA AND ICU HOSPITALIZATION
Time frame: 30 DAYS
Plan to share: Undecided
This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Nacional Profesor Alejandro Posadas